Stryker is one of the world’s leading medical technology companies and large supplier of orthopedic implants in this segment. The company with its about 33,000 employees worldwide offers a diverse array of innovative medical technologies, including reconstructive, medical, surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker is committed to helping patients by developing innovative solutions based on sound technological principles, creative thinking, and decades of established clinical experience. Long year experience in developing and producing orthopedic components qualify this partner for taking over the commercial lead of exploitation for the highly innovative EV-hydrogel-TiO2 based bioactive surface-coated endoprothesis. The company has many R&D centres across the world with its European headquarter in Amsterdam, the Netherlands. Stryker is leading the industry for additive manufacturing and industrialise 3D porous printing; numerous orthopaedic implants are on the market using additive manufacturing technique for uncemented implant to bone fixation. The task for the project is to supply the titanium backing material, which is used for hydrogel coating along with its biomechanical and biocompatibility evaluation. Furthermore, Stryker with its longstanding experience in this field is involved in the business development and exploitation of the expected results.
Contact
Dr. Eric Garling
Phone +31 6 467 135 18
eric.garling@stryker.com
https://www.stryker.com/us/en/international/europe/european-regional-headquarters.html
Dr. Ralf Schwanbeck
Phone +49 4348 702 433
ralf.schwanbeck@stryker.com